Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Statins and aortic stenosis progression: are biologic targets still an option?

× No keyword cloud information.

9 in total

1. New insights into the progression of aortic stenosis: implications for secondary prevention.

Authors: S Palta; A M Pai; K S Gill; R G Pai
Journal: Circulation Date: 2000-05-30 Impact factor: 29.690

2. Comparison of cardiovascular risk and lipid profiles in patients undergoing aortic valve surgery versus those undergoing coronary artery bypass grafting.

Authors: G M Novaro; G L Pearce; D L Sprecher; B P Griffin
Journal: J Heart Valve Dis Date: 2001-01

3. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis.

Authors: G M Novaro; I Y Tiong; G L Pearce; M S Lauer; D L Sprecher; B P Griffin
Journal: Circulation Date: 2001-10-30 Impact factor: 29.690

4. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis.

Authors: S Joanna Cowell; David E Newby; Robin J Prescott; Peter Bloomfield; John Reid; David B Northridge; Nicholas A Boon
Journal: N Engl J Med Date: 2005-06-09 Impact factor: 91.245

Review 5. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis.

Authors: Raphael Rosenhek; Florian Rader; Nicole Loho; Harald Gabriel; Maria Heger; Ursula Klaar; Michael Schemper; Thomas Binder; Gerald Maurer; Helmut Baumgartner
Journal: Circulation Date: 2004-08-30 Impact factor: 29.690

6. Development and progression of aortic valve stenosis: atherosclerosis risk factors--a causal relationship? A clinical morphologic study.

Authors: E R Mohler; M J Sheridan; R Nichols; W P Harvey; B F Waller
Journal: Clin Cardiol Date: 1991-12 Impact factor: 2.882

Statins and aortic stenosis progression: are biologic targets still an option?

1. New insights into the progression of aortic stenosis: implications for secondary prevention.

2. Comparison of cardiovascular risk and lipid profiles in patients undergoing aortic valve surgery versus those undergoing coronary artery bypass grafting.

3. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis.

4. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis.

Review 5. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis.

6. Development and progression of aortic valve stenosis: atherosclerosis risk factors--a causal relationship? A clinical morphologic study.

7. Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy.

8. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells.

9. Attenuation of chronic hypoxic pulmonary hypertension by simvastatin.